Position in BSX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Derivatives in BSX
reported options exposure · as of Jun 30, 2026CallValue
$2,134,000
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026Stonepine Capital Management, LLC holds $5,056,076 across 6 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TELA |
TELA Bio, Inc.
|
2,662,427 | $1,996,820 | |
| 2 | LUNG |
Pulmonx Corp
|
815,436 | $1,060,066 | |
| 3 | MXCT |
Maxcyte, Inc.
|
751,606 | $924,475 | |
| 4 | QTI |
Qt Imaging Holdings, Inc.
|
100,000 | $407,000 | |
| 5 | SINT |
Sintx Technologies, Inc.
|
209,205 | $391,213 | |
| 6 | SENS |
Senseonics Holdings, Inc.
|
48,680 | $276,502 |
All Filings in BSX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,134,000 | 50,000 | Call | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||